Novavax
NVAX
#5751
Rank
$1.12 B
Marketcap
$6.91
Share price
0.73%
Change (1 day)
-16.75%
Change (1 year)

Earnings for Novavax (NVAX)

Earnings in 2025 (TTM): $0.37 Billion USD

According to Novavax's latest financial reports the company's current earnings are $1.02 Billion USD. In 2024 the company made an earning of -$0.16 Billion USD, an increase over its 2023 earnings that were of -$0.53 Billion USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novavax from 1996 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) $0.37 B-339.55%
2024 -$0.16 Billion-70.39%
2023 -$0.53 Billion-16.59%
2022 -$0.64 Billion-62.58%
2021 -$1.7 Billion320.54%
2020 -$0.41 Billion234.22%
2019 -$0.13 Billion-30.17%
2018 -$0.18 Billion1.69%
2017 -$0.17 Billion-36.44%
2016 -$0.27 Billion70.4%
2015 -$0.16 Billion89.27%
2014 -$82.79 Million59.83%
2013 -$51.8 Million81.9%
2012 -$28.48 Million50.33%
2011 -$18.95 Million
2009 -$37.39 Million8.8%
2008 -$34.36 Million18.01%
2007 -$29.12 Million18.33%
2006 -$24.61 Million168.31%
2005 -$9.18 Million-62.51%
2004 -$24.47 Million52.4%
2003 -$16.06 Million-28.21%
2002 -$22.36 Million
2000 -$12.75 Million177%
1999 -$4.6 Million-11.54%
1998 -$5.2 Million10.64%
1997 -$4.7 Million-9.62%
1996 -$5.2 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Agenus
AGEN
$20.66 M-94.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
-$0.26 Billion-167.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
$0.16 B-55.92%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-$6.62 Million-101.76%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
$13.09 B 3,390.75%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
$11.85 B 3,060.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
$16.41 B 4,278.51%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NanoViricides
NNVC
-$9.47 Million-102.52%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
$9.32 B 2,386.17%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
-$0.26 Billion-168.33%๐Ÿ‡บ๐Ÿ‡ธ USA